Several Indian largecap companies showed strong financial results in the December quarter. Trent and Vedanta were among ten firms that achieved substantial profit growth, with some seeing increases up to 125 percent year-on-year. Other companies like Muthoot Finance, Siemens Energy, and TVS Motor also reported healthy profit jumps.Read More
HDFC AMC MD & CEO Navneet Munot advises investors against momentum-driven decisions, emphasizing disciplined, multi-asset investing. He highlights India’s structural growth story despite near-term volatility and suggests a balanced approach for long-term wealth creation, advocating for staggered investments through SIPs over market timing.Read More
India’s equity markets present a contrarian opportunity as macro stability and bottoming earnings signal a constructive outlook, particularly for largecaps, midcaps, and cyclicals. Fund manager Siddharth Vora highlights multi-decadal underperformance versus global peers as a key indicator for potential outperformance, with his fund strategically overweighting metals, PSU banks, and energy.Read More
Cochin Shipyard secured a significant $360 million contract to build six LNG-powered container vessels for France’s CMA CGM Group. This deal boosts its order book to Rs 23,000 crore, enhancing future revenue visibility. The first vessel is slated for delivery by February 2029, with subsequent deliveries at two per year. This marks a key expansion into sustainable shipbuilding.Read More
Dr. Reddy’s Laboratories is set to attract investor attention after acquiring the India trademarks for specialty brands Progynova® and Cyclo-Progynova® from Mercury Pharma Group Limited for USD 32.15 million. This domestic acquisition significantly strengthens Dr. Reddy’s gynecology portfolio and marks its entry into the Hormone Replacement Therapy segment in India.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
